Precision Optics (US:POCI) Globenewswireยท2025-09-29 20:30Core Insights - Precision Optics Corporation reported a record quarterly revenue of $6.2 million for Q4 2025, representing a 31% increase year-over-year, driven by strong demand from aerospace and surgical robotics sectors [6][7] - The company anticipates fiscal year 2026 revenue to exceed $25 million, indicating over 30% growth compared to fiscal year 2025 [6][8] - The appointment of Joseph Traut as the new Chief Operating Officer is expected to enhance operational efficiency and production capacity [9][10] Financial Highlights for Q4 2025 - Quarterly revenue reached $6.2 million, up from $4.7 million in Q4 2024, marking a growth of approximately 31% [6][7] - Production revenue was $5.1 million, a 54% increase from $2.8 million in the same quarter last year [7] - Gross margins decreased to 13.0% from 21.7% in the same quarter of the previous fiscal year [7] Financial Highlights for FY 2025 - Total revenue for FY 2025 was $19.1 million, consistent with the previous fiscal year [7][24] - Production revenue increased by 34% to $14.2 million compared to $10.6 million in FY 2024 [7] - The net loss for FY 2025 was $(5.8) million, compared to $(3.0) million in FY 2024 [7][24] FY 2026 Financial Guidance - The company projects FY 2026 revenue to exceed $25 million, representing a growth of approximately 31% over FY 2025 [6][8] - Expected gross margin for FY 2026 is approximately 30%, an improvement from 18% in FY 2025 [7][8] - Projected Adjusted EBITDA for FY 2026 is approximately $0.5 million, compared to $(3.7) million in FY 2025 [7][8] Operational Challenges and Improvements - Margins were impacted by production yields, staffing, and efficiency challenges, along with unexpected tariff costs [8] - The company has renegotiated pricing agreements to address yield shortfalls and anticipates improvements in gross margins throughout FY 2026 [8] - New product development initiatives are expected to enhance the utilization of engineering resources [8] Leadership Changes - Joseph Traut has been appointed as the new Chief Operating Officer, effective October 1, 2025, bringing extensive experience in operations management within the medical device sector [9][10] - The company expects Traut's expertise to contribute significantly to scaling operations and improving manufacturing efficiency [10]